Showing 541 - 560 results of 1,767 for search '(( i point decrease ) OR ( 10 ((greater decrease) OR (((a decrease) OR (mean decrease)))) ))*', query time: 0.20s Refine Results
  1. 541

    Flow and Fracture Behaviour of Tungsten Fiber Reinforced Superalloy Composites-Effect Of Specimen Geometry by Kandeil, A. Y.

    Published 1989
    “…I. niaxial compression forging was performed at a constant true strain rate of 3x10^ S , with temperature as parameter. …”
    Get full text
  2. 542
  3. 543
  4. 544
  5. 545
  6. 546
  7. 547
  8. 548
  9. 549
  10. 550
  11. 551

    Lipid-lowering therapies for atherosclerosis: Statins, fibrates, ezetimibe and pcsk9 monoclonal antibodies by Ali, A.H.

    Published 2021
    “…Recent evidence classifies atherosclerosis as a latent disease affecting all-sized arteries with a predilection for arterial branching points of decreased or absent blood supply. Atherosclerosis is not only a lipid metabolism disorder, but is also a chronic inflammatory one. …”
    Get full text
    Get full text
    Get full text
  12. 552
  13. 553
  14. 554
  15. 555
  16. 556

    Novel potentials of the DPP-4 inhibitor sitagliptin against ischemia-reperfusion (I/R) injury in rat ex-vivo heart model by Al-Awar A.

    Published 2018
    “…Sitg oral treatment of different doses (25, 50, 100, and 150 mg/kg/day), or saline as a Control. Hearts were then isolated and subjected to two different I/R injury protocols: 10 min perfusion, 45 min regional ischemia, and 120 min reperfusion for infarct size (IS) measurement, or: 10 min perfusion, 45 min regional ischemia and 10 min reperfusion for biochemical analysis: nitric oxide synthases (NOSs) and DPP-4 activity, glucagon-like peptide-1 (GLP-1), Calcium, transient receptor potential vanilloid (TRPV)-1 and calcitonin gene-related peptide (CGRP) levels, transient receptor potential canonical (TRPC)-1 and e-NOS protein expression. …”
    Get full text
    Get full text
  17. 557
  18. 558
  19. 559
  20. 560